PL295403A1 - - Google Patents
Info
- Publication number
- PL295403A1 PL295403A1 PL92295403A PL29540392A PL295403A1 PL 295403 A1 PL295403 A1 PL 295403A1 PL 92295403 A PL92295403 A PL 92295403A PL 29540392 A PL29540392 A PL 29540392A PL 295403 A1 PL295403 A1 PL 295403A1
- Authority
- PL
- Poland
- Prior art keywords
- thiomorpholino
- thiazolidinyl
- azetidinyl
- alzheimer
- dioxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919116039A GB9116039D0 (en) | 1991-07-25 | 1991-07-25 | Substituted cyclopropylamino-1,3,5-triazines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL295403A1 true PL295403A1 (pl) | 1993-02-08 |
| PL169247B1 PL169247B1 (pl) | 1996-06-28 |
Family
ID=10698941
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL92311241A PL169646B1 (pl) | 1991-07-25 | 1992-07-24 | Sposób wytwarzania nowych pochodnych cykIopropyloamino-1,3,5-triazyny PL PL PL PL PL PL PL PL PL |
| PL92295403A PL169247B1 (pl) | 1991-07-25 | 1992-07-24 | Sposób wytwarzania nowych pochodnych cyklopropyloamino-1,3,5-triazyny PL PL PL PL PL PL PL PL PL |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL92311241A PL169646B1 (pl) | 1991-07-25 | 1992-07-24 | Sposób wytwarzania nowych pochodnych cykIopropyloamino-1,3,5-triazyny PL PL PL PL PL PL PL PL PL |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5258513A (pl) |
| EP (1) | EP0527117B1 (pl) |
| JP (1) | JP3138540B2 (pl) |
| KR (1) | KR100221400B1 (pl) |
| AT (1) | ATE159719T1 (pl) |
| AU (1) | AU648424B2 (pl) |
| CA (1) | CA2072680A1 (pl) |
| DE (1) | DE69222903T2 (pl) |
| DK (1) | DK0527117T3 (pl) |
| ES (1) | ES2109332T3 (pl) |
| FI (1) | FI923314A7 (pl) |
| GB (1) | GB9116039D0 (pl) |
| GR (1) | GR3026017T3 (pl) |
| HU (1) | HU218207B (pl) |
| IE (1) | IE922422A1 (pl) |
| NO (1) | NO300683B1 (pl) |
| NZ (1) | NZ243681A (pl) |
| PL (2) | PL169646B1 (pl) |
| RU (1) | RU2095353C1 (pl) |
| UA (1) | UA27749C2 (pl) |
| ZA (1) | ZA924920B (pl) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643960A (en) * | 1994-04-15 | 1997-07-01 | Duke University | Method of delaying onset of alzheimer's disease symptoms |
| US6025395A (en) | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
| US6400819B1 (en) * | 1996-03-28 | 2002-06-04 | Hitachi, Ltd. | Method and apparatus for executing communication in real-time and data structure for real-time data communication |
| WO1998011076A1 (de) * | 1996-09-13 | 1998-03-19 | Lonza Ag | Verfahren zur herstellung von 6-methyl-2-methylamino-4-methoxy-1,3,5-triazin |
| US6292261B1 (en) | 1998-05-22 | 2001-09-18 | Cyberoptics Corporation | Rotary sensor system with at least two detectors |
| US6538750B1 (en) | 1998-05-22 | 2003-03-25 | Cyberoptics Corporation | Rotary sensor system with a single detector |
| FI105684B (fi) * | 1998-08-21 | 2000-09-29 | Neste Chemicals Oy | Enantioselektiiviset kiraaliset sulfidikatalyytit, menetelmä niiden valmistamiseksi ja niiden käyttö stereoselektiivisiin epoksidointi-, syklopropanointi- ja atsiridinointireaktioihin |
| US6384032B1 (en) * | 1999-06-17 | 2002-05-07 | Shionogi Bioresearch Corp. | Inhibitors of IL-12 production |
| EP1185528A4 (en) * | 1999-06-17 | 2003-03-26 | Shionogi Biores Corp | INHIBITORS OF IL-12 PRODUCTION |
| CZ302882B6 (cs) | 1999-08-21 | 2012-01-04 | Nycomed Gmbh | Farmaceutický prostredek |
| CN1098876C (zh) * | 1999-09-21 | 2003-01-15 | 上海赛璐化工股份有限公司 | 一种长碳链共聚酰胺及其制备方法 |
| US6943161B2 (en) * | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
| US6680315B2 (en) * | 2000-06-15 | 2004-01-20 | Synta Pharmaceuticals Corp. | Triazine compounds |
| MXPA04005181A (es) * | 2001-11-30 | 2005-06-17 | Synta Pharmaceuticals Corp | Compuestos de pirimidina. |
| RU2234500C1 (ru) * | 2002-11-15 | 2004-08-20 | Кубанский государственный аграрный университет | Способ получения простых макроэфиров сим-триазинового ряда |
| US7323462B2 (en) | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7153824B2 (en) | 2003-04-01 | 2006-12-26 | Applied Research Systems Ars Holding N.V. | Inhibitors of phosphodiesterases in infertility |
| TWI359017B (en) * | 2003-11-10 | 2012-03-01 | Synta Pharmaceuticals Corp | Heteroaryl-hydrazone compounds |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EA201391254A1 (ru) | 2011-03-01 | 2014-02-28 | Синерджи Фармасьютикалз Инк. | Способ получения агонистов гуанилатциклазы c |
| ES2657551T3 (es) * | 2011-08-08 | 2018-03-05 | Immunomet Therapeutics Inc. | Derivados de biguanida sustituidos en N1-amina cíclica-N5, métodos de preparación de los mismos y composición farmacéutica que comprende los mismos |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CN105764916B (zh) | 2013-06-05 | 2021-05-18 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
| EP3492106B1 (en) | 2013-08-09 | 2021-02-17 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| EP3972599B1 (en) | 2019-05-21 | 2025-10-22 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160831A (en) * | 1976-08-19 | 1979-07-10 | Ciba-Geigy Corporation | Novel insecticides |
| EP0003749B1 (de) * | 1978-02-03 | 1982-09-15 | Ciba-Geigy Ag | 2-Methylthio-4-cyclopropylamino-6-(Alpha,Beta-dimethylpropylamino)-s-triazin und die Verwendung von Triazinderivaten als Meerwasseralgizide |
| GB8819494D0 (en) * | 1988-08-16 | 1988-09-21 | Ucb Sa | Use of 2-amino-4-morpholino-6-propyl-1 3 5-triazines for preparation of psychotropic medicaments |
| GB8819493D0 (en) * | 1988-08-16 | 1988-09-21 | Ucb Sa | 2-amino-4-morpholino-6-propyl-1 3 5-triazines |
-
1991
- 1991-07-25 GB GB919116039A patent/GB9116039D0/en active Pending
-
1992
- 1992-06-29 CA CA002072680A patent/CA2072680A1/en not_active Abandoned
- 1992-07-02 ZA ZA924920A patent/ZA924920B/xx unknown
- 1992-07-09 AT AT92870101T patent/ATE159719T1/de not_active IP Right Cessation
- 1992-07-09 DE DE69222903T patent/DE69222903T2/de not_active Expired - Fee Related
- 1992-07-09 DK DK92870101.0T patent/DK0527117T3/da active
- 1992-07-09 ES ES92870101T patent/ES2109332T3/es not_active Expired - Lifetime
- 1992-07-09 EP EP92870101A patent/EP0527117B1/fr not_active Expired - Lifetime
- 1992-07-20 US US07/914,583 patent/US5258513A/en not_active Expired - Fee Related
- 1992-07-21 FI FI923314A patent/FI923314A7/fi unknown
- 1992-07-23 NO NO922922A patent/NO300683B1/no not_active IP Right Cessation
- 1992-07-23 AU AU20534/92A patent/AU648424B2/en not_active Ceased
- 1992-07-23 NZ NZ243681A patent/NZ243681A/en unknown
- 1992-07-24 HU HU9202441A patent/HU218207B/hu not_active IP Right Cessation
- 1992-07-24 PL PL92311241A patent/PL169646B1/pl unknown
- 1992-07-24 JP JP04198702A patent/JP3138540B2/ja not_active Expired - Fee Related
- 1992-07-24 RU SU925052292A patent/RU2095353C1/ru active
- 1992-07-24 PL PL92295403A patent/PL169247B1/pl unknown
- 1992-07-24 KR KR1019920013231A patent/KR100221400B1/ko not_active Expired - Fee Related
- 1992-07-24 IE IE242292A patent/IE922422A1/en not_active Application Discontinuation
-
1993
- 1993-06-18 UA UA93003144A patent/UA27749C2/uk unknown
- 1993-08-09 US US08/103,119 patent/US5348956A/en not_active Expired - Fee Related
-
1998
- 1998-01-28 GR GR980400187T patent/GR3026017T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU218207B (hu) | 2000-06-28 |
| EP0527117B1 (fr) | 1997-10-29 |
| EP0527117A1 (fr) | 1993-02-10 |
| ES2109332T3 (es) | 1998-01-16 |
| KR930002327A (ko) | 1993-02-23 |
| NO300683B1 (no) | 1997-07-07 |
| HU9202441D0 (en) | 1992-10-28 |
| FI923314A0 (fi) | 1992-07-21 |
| JP3138540B2 (ja) | 2001-02-26 |
| NO922922D0 (no) | 1992-07-23 |
| KR100221400B1 (ko) | 1999-09-15 |
| GB9116039D0 (en) | 1991-09-11 |
| NO922922L (no) | 1993-01-26 |
| GR3026017T3 (en) | 1998-04-30 |
| AU2053492A (en) | 1993-01-28 |
| UA27749C2 (uk) | 2000-10-16 |
| ATE159719T1 (de) | 1997-11-15 |
| DE69222903T2 (de) | 1998-03-26 |
| NZ243681A (en) | 1997-06-24 |
| ZA924920B (en) | 1993-04-28 |
| IE922422A1 (en) | 1993-01-27 |
| US5258513A (en) | 1993-11-02 |
| JPH06220026A (ja) | 1994-08-09 |
| AU648424B2 (en) | 1994-04-21 |
| RU2095353C1 (ru) | 1997-11-10 |
| US5348956A (en) | 1994-09-20 |
| PL169646B1 (pl) | 1996-08-30 |
| DK0527117T3 (da) | 1998-05-18 |
| PL169247B1 (pl) | 1996-06-28 |
| HUT66218A (en) | 1994-10-28 |
| FI923314L (fi) | 1993-01-26 |
| FI923314A7 (fi) | 1993-01-26 |
| DE69222903D1 (de) | 1997-12-04 |
| CA2072680A1 (en) | 1993-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL295403A1 (pl) | ||
| GB8808433D0 (en) | Therapeutic agents | |
| NZ226415A (en) | Spiro-oxathiolane/quinuclidine derivatives and pharmaceutical compositions | |
| HUT60735A (en) | Process for producing piperidyloxy and quinuclidinyloxy isoxazole derivatives and pharmaceutical compositions comprising such compounds | |
| GR3034023T3 (en) | Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them. | |
| TW222630B (pl) | ||
| IN167549B (pl) | ||
| HU912673D0 (en) | 3-(1,2-benzisoxazole-3-yl)-4-pyridine-amines and their derivatives | |
| IL107001A0 (en) | Tetrahydroacridine amino compounds and pharmaceutical compositions containing them | |
| EP0125679A3 (en) | Spiro(indolo(1,7-ab)(1,5)benzodiazepine-2,4'-piperidines) and intermediates, a process for the preparation thereof and their use as medicaments | |
| IL98914A0 (en) | Process for the preparation of 6-(substituted aminopropionyl)derivatives of forskolin | |
| CA2296901A1 (en) | Piperidine derivates having anxiolytic effect | |
| ATE133953T1 (de) | Hexahydro-1h-chino(4,3,2-ef>(1,4>benzoxazepine und verwandte verbindungen und zwischenprodukte zur herstellung und verwendung als arzneimittel |